[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"mental-retardation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:mental-retardation":33},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,52,85,111],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":35,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100567463","magnetoencephalography-in-children-100567463",false,"NCT06668519","Magnetoencephalography in Children","An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders","Inclusion Criteria:\n\n1. aged 1 month-18 years old (date of investigate minus date of birth)\n2. epilepsy\n3. intracranial tumors\n4. cerebrovascular diseases\n5. autism\n6. mental retardation\n7. ADHD\n8. tic disorder\n9. neuropsychiatric disorders\n\nExclusion Criteria:\n\n1.Unable to cooperate with the exam of MEG","ALL","1 Month","18 Years",{"count":20,"type":21},1500,"ESTIMATED","3 Years","OBSERVATIONAL","This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.",[26,27,28,29,30,31,32,33,34],"Epilepsy","Intracranial Tumors","Cerebrovascular Disease","Autism","ADHD - Attention Deficit Disorder With Hyperactivity","Neuropsychiatric Disorders","Tic Disorder, Childhood","Mental Retardation","Developmental Disabilities",[36,37,38],"neurodevelopmental diseases","magnetoencephalography","pediatric","RECRUITING","2026-03-24",{"date":42,"type":43},"2026-03-25","ACTUAL",{"date":45,"type":43},"2024-09-25",{"date":47,"type":21},"2027-12-30",{"name":49,"class":50},"Children's Hospital of Fudan University","OTHER",1,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":4,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":16,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":68,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":51},"100595121","effects-of-different-dual-task-exercises-in-children-with-mild-mental-retardation-100595121","NCT07028333","Effects of Different Dual-Task Exercises in Children With Mild Mental Retardation","Effects of Different Dual-Task Exercises on Motor and Cognitive Functions in Children With Mild Mental Retardation","Inclusion Criteria:\n\n* Obtaining parental consent\n* Having an Intelligence Quotient between 51-70\n* Having an educational diagnosis of mild mental retardation\n* Being between the ages of 8-12\n* Ability to understand Turkish instructions\n* Ability to follow commands during the exercise program\n* No additional disabilities that would prevent participation in the program\n\nExclusion Criteria:\n\n* Having a metabolic or systemic disease\n* Engaging in regular physical exercise\n* Having visual or hearing impairments\n* Presence of any condition that would interfere with compliance to assessment parameters","8 Years","12 Years",{"count":62,"type":21},33,"INTERVENTIONAL",[65],"NA","The purpose of this study is to investigate the effects of motor-motor and motor-cognitive dual-task exercises applied to children with mild mental retardation on their functional mobility, balance, cognitive function, and quality of life.",[33],[69,70,71,72,73,74,75],"Dual-Task Exercise","Motor Function","Cognitive Function","Rehabilitation","mental retardation","Balance","physiotherapy and Rehabilitation","2025-06-11",{"date":78,"type":43},"2025-06-19",{"date":80,"type":43},"2024-11-15",{"date":82,"type":21},"2025-11-10",{"name":84,"class":50},"Istanbul University - Cerrahpasa",{"id":86,"slug":87,"hasResults":11,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":4,"eligibilityCriteria":91,"healthyVolunteers":11,"sex":16,"minAge":92,"maxAge":18,"enrollmentInfo":93,"targetDuration":95,"studyType":23,"phases":4,"briefSummary":96,"conditions":97,"keywords":4,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":51},"100581334","development-and-application-of-a-diagnosis-and-treatment-system-for-childrens-brain-diseases-based-on-knowledge-graphs-and-large-models-100581334","NCT06848959","Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models","Jiangsu Provincial Hospital of Traditional Chinese Medicine","Inclusion Criteria:\n\n* 1\\. meet diagnostic criteria for CP ID TD ADHD ASD; 2. gender is not limited;\n\nExclusion Criteria:\n\n* 1\\. CP ID TD ASD due to chorea hepatomegaly hearing abnormality and pharmacogenetic factors;\n* 2\\. Children with other major mental illnesses (e.g. schizophrenia) or organic diseases (e.g. congenital heart disease);","2 Years",{"count":94,"type":21},2000,"2 Months","Using the knowledge graph and big model technology of combining Chinese and Western medicine we construct a popularization and prevention system for childhood encephalopathy an assisted decision-making system for childhood encephalopathy and a follow-up tracking question and answer system for childhood encephalopathy patients.",[98,33,99,100,101],"Cerebral Palsy","Tourette&#39;s Syndrome","Attention Deficit Hyperactivity Disorder","Autism Spectrum Disorders","2025-02-22",{"date":104,"type":43},"2025-02-27",{"date":106,"type":43},"2024-01-01",{"date":108,"type":21},"2025-12-31",{"name":110,"class":50},"Yun Liu,PhD",{"id":112,"slug":113,"hasResults":11,"nctId":114,"briefTitle":115,"officialTitle":115,"acronym":4,"eligibilityCriteria":116,"healthyVolunteers":11,"sex":16,"minAge":18,"maxAge":4,"enrollmentInfo":117,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":119,"conditions":120,"keywords":125,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":133,"completionDateStruct":135,"leadSponsor":137,"locationsCount":51},"100566611","a-study-on-the-preference-of-risperidone-dosage-forms-100566611","NCT06657430","A Study on the Preference of Risperidone Dosage Forms","Inclusion Criteria:\n\n* Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.\n\nExclusion Criteria:\n\n* Have difficulty reading and understanding Chinese or refuse to participate in the study.",{"count":118,"type":21},1000,"This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.",[121,122,123,124,33],"Schizophrenia","Bipolar Affective Disorder","Autism Spectrum Disorder","Conduct Disorder",[126,127,128,129],"risperidone","patch","cross-sectional study","preference","2024-10-23",{"date":132,"type":43},"2024-10-24",{"date":134,"type":43},"2024-09-19",{"date":136,"type":21},"2025-02-28",{"name":138,"class":50},"Shanghai Mental Health Center"]